Featured Products

My Quote Request

No products added yet

6505-01-145-8827

20 Products

NDC00603-3265-21

DICYCLOMINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505011458827

NSN

6505-01-145-8827

View More Info

NDC00603-3265-21

DICYCLOMINE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505011458827

NSN

6505-01-145-8827

MFG

GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS DICYCLOMINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DICYCLOMINE HYDROCHLORIDE CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,MERRELL-DOW PHARM

DELTASONE

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505011460539

NSN

6505-01-146-0539

View More Info

DELTASONE

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505011460539

NSN

6505-01-146-0539

MFG

PHARMACIA & UPJOHN COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PREDNISONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISONE TABLETS USP 10MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

DELTASONE TABLETS

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505011460539

NSN

6505-01-146-0539

View More Info

DELTASONE TABLETS

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505011460539

NSN

6505-01-146-0539

MFG

PHARMACIA & UPJOHN COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PREDNISONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISONE TABLETS USP 10MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00009-0193-02

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505011460539

NSN

6505-01-146-0539

View More Info

NDC00009-0193-02

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505011460539

NSN

6505-01-146-0539

MFG

PHARMACIA & UPJOHN COMPANY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PREDNISONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISONE TABLETS USP 10MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00054-4730-29

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505011460539

NSN

6505-01-146-0539

View More Info

NDC00054-4730-29

PREDNISONE TABLETS,USP

NSN, MFG P/N

6505011460539

NSN

6505-01-146-0539

MFG

CARDINAL HEALTH 200 LLC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PREDNISONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PREDNISONE TABLETS USP 10MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

12-405-055

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505011460540

NSN

6505-01-146-0540

View More Info

12-405-055

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505011460540

NSN

6505-01-146-0540

MFG

COBE LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.250 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 105.500 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 137.500 MILLIEQUIVALENTS SODIUM ION PER LITER AND 36 MEQ. ACETATE ION PER LITER AND 0.75 MEQ. MAGNESIUM ION PER LITER
PRIMARY CONTAINER CONTENT QUANTITY: 55.000 GALLONS
PRIMARY CONTAINER TYPE: DRUM
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 34 PARTS WATER

RENALYTE 12-405

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505011460540

NSN

6505-01-146-0540

View More Info

RENALYTE 12-405

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505011460540

NSN

6505-01-146-0540

MFG

COBE LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.250 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 105.500 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 137.500 MILLIEQUIVALENTS SODIUM ION PER LITER AND 36 MEQ. ACETATE ION PER LITER AND 0.75 MEQ. MAGNESIUM ION PER LITER
PRIMARY CONTAINER CONTENT QUANTITY: 55.000 GALLONS
PRIMARY CONTAINER TYPE: DRUM
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 34 PARTS WATER

NDC00008-0051-02

OXAZEPAM CAPSULES,USP

NSN, MFG P/N

6505011461137

NSN

6505-01-146-1137

View More Info

NDC00008-0051-02

OXAZEPAM CAPSULES,USP

NSN, MFG P/N

6505011461137

NSN

6505-01-146-1137

MFG

AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXAZEPAM CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP FOR DOD, WYETH-AYERST LABORATORIES

NDC00536-4879-01

OXAZEPAM CAPSULES,USP

NSN, MFG P/N

6505011461137

NSN

6505-01-146-1137

View More Info

NDC00536-4879-01

OXAZEPAM CAPSULES,USP

NSN, MFG P/N

6505011461137

NSN

6505-01-146-1137

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXAZEPAM CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP FOR DOD, WYETH-AYERST LABORATORIES

SERAX

OXAZEPAM CAPSULES,USP

NSN, MFG P/N

6505011461137

NSN

6505-01-146-1137

View More Info

SERAX

OXAZEPAM CAPSULES,USP

NSN, MFG P/N

6505011461137

NSN

6505-01-146-1137

MFG

AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXAZEPAM CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP FOR DOD, WYETH-AYERST LABORATORIES

SERAX CAPSULES

OXAZEPAM CAPSULES,USP

NSN, MFG P/N

6505011461137

NSN

6505-01-146-1137

View More Info

SERAX CAPSULES

OXAZEPAM CAPSULES,USP

NSN, MFG P/N

6505011461137

NSN

6505-01-146-1137

MFG

AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXAZEPAM CAPSULES USP 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP FOR DOD, WYETH-AYERST LABORATORIES

NDC00732-1904-12

HEPARIN LOCK FLUSH SOLUTION,USP

NSN, MFG P/N

6505011461138

NSN

6505-01-146-1138

View More Info

NDC00732-1904-12

HEPARIN LOCK FLUSH SOLUTION,USP

NSN, MFG P/N

6505011461138

NSN

6505-01-146-1138

MFG

PHARMA-SERVE INC TORIGIAN LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 UNITS HEPARIN SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
TOTAL PRIMARY CONTAINER QUANTITY: 100

NDC00186-0175-14

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION,USP

NSN, MFG P/N

6505011461139

NSN

6505-01-146-1139

View More Info

NDC00186-0175-14

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION,USP

NSN, MFG P/N

6505011461139

NSN

6505-01-146-1139

MFG

ASTRA PHARMACEUTICALS LP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.001 PERCENTAGE, W/V EPINEPHRINE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIDOCAINE HYDROCHLORIDE & EPINEPHRINE INJ USP 1.8ML CARTRIDGE 100S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD; FOR DENTAL USE; USE W/SYRINGE 6515-01-010-8761
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.800 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE
SPECIAL FEATURES: EPINEPRINE 1:100,000
TOTAL PRIMARY CONTAINER QUANTITY: 100

XYLOCAINE ASTRAPAK

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION,USP

NSN, MFG P/N

6505011461139

NSN

6505-01-146-1139

View More Info

XYLOCAINE ASTRAPAK

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION,USP

NSN, MFG P/N

6505011461139

NSN

6505-01-146-1139

MFG

ASTRA PHARMACEUTICALS LP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.001 PERCENTAGE, W/V EPINEPHRINE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIDOCAINE HYDROCHLORIDE & EPINEPHRINE INJ USP 1.8ML CARTRIDGE 100S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD; FOR DENTAL USE; USE W/SYRINGE 6515-01-010-8761
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.800 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE
SPECIAL FEATURES: EPINEPRINE 1:100,000
TOTAL PRIMARY CONTAINER QUANTITY: 100

LOXITANE

LOXAPINE HYDROCHLORIDE INJECTION

NSN, MFG P/N

6505011461624

NSN

6505-01-146-1624

View More Info

LOXITANE

LOXAPINE HYDROCHLORIDE INJECTION

NSN, MFG P/N

6505011461624

NSN

6505-01-146-1624

MFG

AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS LOXAPINE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10

LOXITANE-IM

LOXAPINE HYDROCHLORIDE INJECTION

NSN, MFG P/N

6505011461624

NSN

6505-01-146-1624

View More Info

LOXITANE-IM

LOXAPINE HYDROCHLORIDE INJECTION

NSN, MFG P/N

6505011461624

NSN

6505-01-146-1624

MFG

AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS LOXAPINE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00205-5385-55

LOXAPINE HYDROCHLORIDE INJECTION

NSN, MFG P/N

6505011461624

NSN

6505-01-146-1624

View More Info

NDC00205-5385-55

LOXAPINE HYDROCHLORIDE INJECTION

NSN, MFG P/N

6505011461624

NSN

6505-01-146-1624

MFG

AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS LOXAPINE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10

2F7304

CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION

NSN, MFG P/N

6505011461626

NSN

6505-01-146-1626

View More Info

2F7304

CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION

NSN, MFG P/N

6505011461626

NSN

6505-01-146-1626

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 430.000 MILLIGRAMS SODIUM CARBONATE, ANHYDROUS ACTIVE INGREDIENT AND 380.000 MILLIGRAMS MAGNESIUM OXIDE ACTIVE INGREDIENT AND 3.24 GRAMS CITRIC ACID HYDROUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: IRRIGATING SOLUTION; IN POUR TYPEPLASTIC BOTTLE WITH BAND AND BAIL; WITHOUT IV TYPE RUBBER STOPPER
TOTAL PRIMARY CONTAINER QUANTITY: 12

AQUALITE

CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION

NSN, MFG P/N

6505011461626

NSN

6505-01-146-1626

View More Info

AQUALITE

CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION

NSN, MFG P/N

6505011461626

NSN

6505-01-146-1626

MFG

ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 430.000 MILLIGRAMS SODIUM CARBONATE, ANHYDROUS ACTIVE INGREDIENT AND 380.000 MILLIGRAMS MAGNESIUM OXIDE ACTIVE INGREDIENT AND 3.24 GRAMS CITRIC ACID HYDROUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: IRRIGATING SOLUTION; IN POUR TYPEPLASTIC BOTTLE WITH BAND AND BAIL; WITHOUT IV TYPE RUBBER STOPPER
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00074-7168-09

CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION

NSN, MFG P/N

6505011461626

NSN

6505-01-146-1626

View More Info

NDC00074-7168-09

CITRIC ACID,MAGNESIUM OXIDE,AND SODIUM CARBONATE SOLUTION

NSN, MFG P/N

6505011461626

NSN

6505-01-146-1626

MFG

ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 430.000 MILLIGRAMS SODIUM CARBONATE, ANHYDROUS ACTIVE INGREDIENT AND 380.000 MILLIGRAMS MAGNESIUM OXIDE ACTIVE INGREDIENT AND 3.24 GRAMS CITRIC ACID HYDROUS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: IRRIGATING SOLUTION; IN POUR TYPEPLASTIC BOTTLE WITH BAND AND BAIL; WITHOUT IV TYPE RUBBER STOPPER
TOTAL PRIMARY CONTAINER QUANTITY: 12